ScottE.LentzMD

Obstetrics & Gynecology • Los Angeles, CA

Gynecologic Oncology

Regional Director, Gynecologic Oncology Southern California Pemanente Medical Group

Join to view full profile

Dr. Lentz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lentz's full profile

Already have an account?

Office
4900 W Sunset Blvd
Suite 3D
Los Angeles, CA 90027
Phone+1 323-783-4011

Fax+1 323-783-4736
Is this information wrong?

Education & Training

LAC+USC Medical Center, University of Southern California School of MedicineGynecologic Oncology, 1998 - 2001
Penn State Milton S Hershey Medical CenterResidency, Obstetrics and Gynecology, 1994 - 1998
Pennsylvania State University College of MedicineClass of 1994
Bucknell UniversityB. S., Biology, 1986 - 1989

Certifications & Licensure

CA State Medical License 1998 - 2026
HI State Medical License 2012 - 2018
PA State Medical License 1995 - 1998
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CREOG Faculty Award for Excellence in Resident Education 2011
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Top Doctors 2009-2012
Outstanding Teaching Award Kaiser Permanente, Los Angeles Medical Center, Department of OB/GYN, 2003
Earl Henriksen Award, Outstanding Attending Physician Southern California Department of OB/GYN, 2002-2003
Outstanding Fellow University of Southern California Department of OB/GYN, 2000-2001
Join now to see all

Clinical Trials

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
Active, not recruiting
Phase 3
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
Completed
Phase 3
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2012 Oct 01
Active, not recruiting
Not Applicable
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
Zachary P Schwartz, Andrew J Li, B J Rimel, Monica M Alvarado, Scott E Lentz, Ilana Cass, Walsh, C.> ;Gynecologic Oncology. 2023 Jun 1
2 citations
Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations
Scott E. Lentz, C. Bethan Powell, Reina Haque, Mary Anne Armstrong, Meredith Anderson, Yiling Liu, Wenqing Jiang, Giulia Chillemi, Sally F. Shaw, Monica Alvarado, Lawr...> ;Gynecologic Oncology. 2020 Dec 1
2 citations
Variation in physician-directed immunohistochemistry screening among women with endometrial cancer.
C.V. Salyer, Makdine Dontsi, Mary Anne Armstrong, Scott E. Lentz, Elizabeth Hoodfar, Bethan Powell> ;International Journal of Gynecological Cancer. 2020 Jul 7
4 citations
Comparison of two Lynch screening strategies in endometrial cancer in a California health system
Scott E. Lentz, C.V. Salyer, Makdine Dontsi, Mary Anne Armstrong, Elizabeth Hoodfar, Monica Alvarado, M. Avila, Nancy T. Nguyen, C. Bethan Powell> ;Gynecologic Oncology. 2020 Jul 1
5 citations
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard u...
Reina Haque, Steven J. Skates, Mary Anne Armstrong, Scott E. Lentz, Meredith Anderson, Wenqing Jiang, Monica Alvarado, Giulia Chillemi, Sally F. Shaw, Lawrence H. Kush...> ;Gynecologic Oncology. 2020 May 1
3 citations
Prediction of Occult Uterine Sarcoma before Hysterectomy for Women with Leiomyoma or Abnormal Bleeding.
Scott E. Lentz, Eve Zaritsky, Lue-Yen Tucker, Catherine Lee, Isabel Lazo, Aki Niihara, Miya Yamamoto, Tina Raine-Bennett> ;Journal of Minimally Invasive Gynecology. 2020 May 1
7 citations
Non-malignant Sequelae after Unconfined Power Morcellation.
Hao M. Zhang, Lee A. Christianson, C Templeman, Scott E. Lentz> ;Journal of Minimally Invasive Gynecology. 2019 Jan 1
29 citations
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
Ramey D. Littell, Lue-Yen Tucker, Tina Raine-Bennett, Ted E. Palen, Eve Zaritsky, Romain Neugebauer, Julia Embry-Schubert, Scott E. Lentz> ;Gynecologic Oncology. 2017 Oct 1
79 citations
Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Tina Raine-Bennett, Lue-Yen Tucker, Eve Zaritsky, Ramey D. Littell, Ted E. Palen, Romain Neugebauer, Allison E. Axtell, Peter M. Schultze, David W. Kronbach, Julia Emb...> ;Obstetrics and Gynecology. 2016 Jan 1
14 citations
Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival.
Michael P. Stany, Pamela J. B. Stone, Juan C. Felix, Charles A. Amezcua, Susan Groshen, Wei Ye, Kathy L. Kyser, Robin S. Howard, Chris M. Zahn, Laila I. Muderspach, Sc...> ;International Journal of Gynecological Pathology. 2015 Jul 1
52 citations
Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies.
Kristine R. Penner, Nicole D. Fleming, Leah Barlavi, A. Axtell, Scott E. Lentz> ;American Journal of Obstetrics and Gynecology. 2015 Feb 1
23 citations
Metformin and breast and gynecological cancer risk among women with diabetes.
Diana Soffer, Jiaxiao Shi, Joanie Chung, Joanne E. Schottinger, Lauren P. Wallner, Rowan T. Chlebowski, Scott E. Lentz, Reina Haque> ;BMJ Open Diabetes Research & Care. 2015 Jan 1
3 citations
Abdominal aortic resection and Y-graft placement to achieve complete cytoreduction in stage IIIc ovarian carcinoma.
Scott E. Lentz, Katherine E. Tierney, Fred A. Weaver, Lynda D. Roman> ;Obstetrics and Gynecology. 2014 Feb 1
6 citations
Operative and anesthetic outcomes in endometrial cancer staging via three minimally invasive methods
Nicole D. Fleming, A. Axtell, Scott E. Lentz> ;Journal of Robotic Surgery. 2012 Dec 1
13 citations
Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer.
Ali Mahdavi, Tania R Tajalli, Ahmed Dalmar, Steven A. Vasilev, Scott E. Lentz, Michael L. Berman> ;International Journal of Gynecological Cancer. 2011 Nov 1
26 citations
Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma
Nicole D. Fleming, Scott E. Lentz, Ilana Cass, Andrew J. Li, Beth Y. Karlan, Christine Walsh> ;Gynecologic Oncology. 2010 Mar 1
14 citations
Pregnancy in a hermaphrodite with a male-predominant mosaic karyotype
Samantha A. Schoenhaus, Scott E. Lentz, Peter Saber, Malcom G. Munro, Seth Kivnick> ;Fertility and Sterility. 2008 Nov 1
68 citations
Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
Scott E. Lentz, Laila I. Muderspach, Juan C. Felix, Wei Ye, Susan Groshen, Charles A. Amezcua> ;Obstetrics and Gynecology. 2004 Jun 1
2 citations
Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S. Berek, Joan P. Cheng, Dennis S. Chi, William A. Cliby, Giuseppe Del Priore, Mark K. Dodson, Bridgette D. Duggan, David M. Ge...> ;Clinical Cancer Research. 2004 Apr 15
45 citations
Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Sanaz Memarzadeh, Sathima Natarajan, Dipika P Dandade, Nora Ostrzega, Peter A. Saber, Ashley Busuttil, Scott E. Lentz, Jonathan S. Berek> ;Obstetrics and Gynecology. 2003 Sep 1
6 citations
Placental pathology in maternal and neonatal myeloproliferative disorders.
Scott E. Lentz, Carol C. Coulson, Christopher D. Gocke, Amy P. Fantaskey> ;Obstetrics and Gynecology. 1998 May 1
25 citations
Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
Ali Mahdavi, Bradley J. Monk, Jennifer Ragazzo, Mark I. Hunter, Scot E. Lentz, Steven A. Vasilev, Krishnansu S. Tewari> ;International Journal of Gynecological Cancer. 2009 Jul 1
Join now to see all

Journal Articles

Operative and anesthetic outcomes in endometrial cancer staging via three minimally invasive methods
Fleming ND, Axtell AE, Lentz SE, J Robot Surg, 1/1/2012
Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?
Fleming ND, Lentz SE, Cass I, Li AJ, Karlan BY, Walsh CS, Gynecol Oncol, 2/1/2011
Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS, Int J Gynecol Cancer, 8/1/2009
Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer
Allison E. Axtell, Margaret H. Lee, Robert E. Bristow, Sean C. Dowdy, William A. Cliby, Steven Raman,John P. Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz, Ilana Cass..., J Clin Oncol, 1/1/2007
Identification of Micrometastases in Histologically Negative Lymph Nodes of Early Stage Cervical Cancer Patients
SE Lentz, LI Muderspach, C Amezcua, et al, Obstet Gynecol, 1/1/2004
Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S. Berek, Joan P. Cheng, Dennis S. Chi, William A. Cliby, Giuseppe Del Priore, Mark K. Dodson, Bridgette D. Duggan, David M. Ge..., Clin Cancer Res, 1/1/2004
Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer
Sanaz Memarzadeh MD, Sathima Natarajan MDb, Dipika P. Dandade MDa, Nora Ostrzega MDb, Peter A. Saber DOd, Ashley Busuttilc, Scott E. Lentz MDd and Jonathan S. Berek MD..., Obstet Gynecol, 1/1/2003
Detection of Residual Disease in Patients Treated for Advanced Ovarian Carcinoma
SE Lentz and L Dubeau, CME Journal of Gynecologic Oncology, 1/1/2000
A Comparison of Placental Pathology in Maternal and Neonatal Myeloproliferative Disorders
SE Lentz and CC Coulson, Obstet Gynecol, 1/1/1998
Join now to see all

Books/Book Chapters

Gynecologic Oncology: Evidence Based Perioperative and Supportive Care
SE LentzWiley & Sons, NJEdition 2nd ,2010

Abstracts/Posters

Impact of Metformin Use on the Incidence of Breast, Ovarian and Endometrial Cancer
Soffer D, Shi J, Chung J, Lentz SE, Haque R, International Gynecologic Cancer Society 14th Biennial Meeting, 10/1/2012
Quality of Life Following Panniculectomy for Gynecologic Cancer Surgery
Picazo R, Diaz ED, Fleming ND, Amneus M, Lentz SE, The Obesity Society Annual Meeting, 9/1/2012
Quality of Life Following Panniculectomy for Gynecologic Cancer Surgery
Picazo R, Diaz ED, Fleming ND, Amneus M, Lentz SE, Western Association of Gynecologic Oncologists Annual Meeting, 6/1/2012
Is Overnight Hospitalization a Necessity in Minimally Invasive Gynecologic Oncology Surgery?
Fleming ND, Penner KR, Barlavi L, Axtell AE, Lentz SE, SGO Annual Meeting on Women's Cancer, 3/1/2012
Same Day Discharge in Minimally Invasive Endometrial Cancer Staging: A Feasibility Study
Penner KP, Fleming ND, Barlavi L, Axtell AE, Lentz SE, SGO Annual Meeting on Women's Cancer, 3/1/2012
Are there Medical Co-morbidities that Predict the Feasibility of Cytoreductive Surgery in Patients with Advanced Ovarian Cancer?
Axtell AE, Engler L, Cass I, Li AJ, Lentz SE, Leuchter RS, Karlan BY, Holschneider CH, IGCS 11th Biennial Meeting, 10/1/2006
Morbidity of Triple Modality therapy in the Management of Early Stage Cervical Cancer
Axtell AE, Lineback F, Lentz SE, Hakimian B, Holschneider CH, Li AJ, Leuchter RS, Lagasse LD, Karlan BY, Cass I, IGCS 11th Biennial Meeting, 10/1/2006
Morbidity Outcomes in Patients with Early Stage Cervical Cancer Treated with Chemoradiation Versus Radiation Alone After Radical Hysterectomy
Axtell AE, Linback F, Lentz SE, Hakimian B, Holschneider CH, Li AJ, Leuchter RS, Lagasse LD, Karlan BY, Cass I, 35th Annual Meeting WAGO, 6/1/2006
Identification of Micrometastases in Histologically Negative Lymph Nodes of Early Stage Cervical Cancer Patients
SE Lentz, LI Muderspach, C Amezcua, et al, Int J Gynecol Cancer, 1/1/2003
Identification of Micrometastases in Histologically Negative Lymph Nodes of Early Stage Cervical Cancer Patients
SE Lentz, LI Muderspach, et al., Gynecol Oncol, 1/1/2002
Telomerase Activity in Abdominal Washings from Patients Undergoing Second-Look Laparotomy for Ovarian Carcinoma
SE Lentz, KA Zempolich, M Rodriguez, et al, Gynecol Oncol, 1/1/2000
Phase I Trial of Gemcitabine and Protracted Oral Etoposide in Recurrent Gynecological Tumors: A Gynecologic Oncology Group Study
SE Lentz, AA Garcia, M Bookman, et al, Proc ASCO, 1/1/2000
Join now to see all

Lectures

Impact of Metformin Use on the Incidence of Breast, Ovarian and Endometrial Cancer
International Gynecologic Cancer Society 14th Biennial Meeting, Vancouver, Canada - 10/1/2012
Quality of Life Following Panniculectomy for Gynecologic Cancer Surgery
Western Association of Gynecologic Oncologists Annual Meeting, Huntington Beach, CA (2012); The Obes - 6/1/2012
Is Overnight Hospitalization a Necessity in Minimally Invasive Gynecologic Oncology Surgery?
Society of Gynecologic Oncology Annual Meeting on Women's Cancer, Austin, TX - 3/1/2012
Same Day Discharge in Minimally Invasive Endometrial Cancer Staging: A Feasibility Study
Society of Gynecologic Oncology Annual Meeting on Women's Cancer, Austin, TX - 3/1/2012
Surgical Video Series --Laparoscopic Extraperitoneal Lymphadenectomy for Morbid obesity in Endometrial Carcinoma
Society of Gynecologic Oncologists 41st Annual Meeting, San Francisco, CA - 3/1/2010
Clinical Implications of Cervical Micrometastases
European Society of Gynecologic Oncology 13th Biannual Meeting, Brussels, Belgium - 4/1/2003
Identification of Micrometastases in Histologically Negative Lymph Nodes of Early Stage Cervical Cancer Patients
Society of Gynecologic Oncologists 35th Annual Meeting, Miami, FL - 3/1/2002
Telomerase Activity in Abdominal Washings from Patients Undergoing Second-Look Laparotomy for Ovarian Carcinoma
Society of Gynecologic Oncologusts 33rd Annual Meeting, San Diego, CA - 2/1/2000
Loss of Heterozygosity in Benign Cystic Teratomas
Society of Memorial Gynecologists, Asheville, NC - 9/1/1997
Mitochondrial DNA Studies of the Origins of the Aboriginal Peoples of the Canary Islands (Guanches)
New Frontiers in Biomedical Research, Hershey Medical Center (1993); Second International Ancient DN - 4/1/1993
Join now to see all

Hospital Affiliations

Kaiser Permanente Los Angeles Medical CenterLos Angeles, California
Kaiser Permanente Panorama City Medical CenterPanorama City, California
Kaiser Permanente South Bay Medical CenterHarbor City, California
Kaiser Permanente West Los Angeles Medical CenterLos Angeles, California